2,134
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Genome-wide study of key genes and scoring system as potential noninvasive biomarkers for detection of suicide behavior in major depression disorder

ORCID Icon, , , & ORCID Icon
Pages 1189-1196 | Received 16 Jul 2020, Accepted 23 Sep 2020, Published online: 24 Oct 2020

References

  • Yang L, Zhao Y, Wang Y, et al. The effects of psychological stress on depression. Curr Neuropharmacol. 2015;13:494–504.
  • Ogłodek E, Szota A, Just M, et al. The role of the neuroendocrine and immune systems in the pathogenesis of depression. Pharmacol Rep. 2014;66:776–781.
  • Weightman MJ, Air TM, Baune BT. A review of the role of social cognition in major depressive disorder. Front Psychiatry. 2014;5:179.
  • Fan HM, Sun XY, Guo W, et al. Differential expression of microRNA in peripheral blood mononuclear cells as specific biomarker for major depressive disorder patients. J Psychiatr Res. 2014;59:45–52.
  • Kitahara Y, Ohta K, Hasuo H, et al. Chronic fluoxetine induces the enlargement of perforant path-granule cell synapses in the mouse dentate gyrus. PloS One. 2016;11:e0147307.
  • Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science. 2012;338:68–72.
  • Turecki G, Brent DA, Gunnell D, et al. Suicide and suicide risk. Nat Rev Dis Primers. 2019;5:74.
  • Cavanagh JT, Carson AJ, Sharpe M, et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med. 2003;33:395–405.
  • Arsenault-Lapierre G, Kim C, Turecki G. Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry. 2004;4:37.
  • Zhao X, Sun S, Zeng X, et al. Expression profiles analysis identifies a novel three-mRNA signature to predict overall survival in oral squamous cell carcinoma. Am J Cancer Res. 2018;8:450–461.
  • Wang T, Xu H, Liu X, et al. Identification of key genes in colorectal cancer regulated by miR-34a. Med Sci Monit. 2017;23:5735–5743.
  • Wray NR, Ripke S, Mattheisen M, et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet. 2018;50:668–681.
  • Pantazatos SP, Huang YY, Rosoklija GB, et al. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity. Mol Psychiatry. 2017;22:760–773.
  • Smith K. Mental health: a world of depression. Nature. 2014;515:181.
  • Rotenstein LS, Ramos MA, Torre M, et al. Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. Jama. 2016;316:2214–2236.
  • Strawbridge R, Young AH, Cleare AJ. Biomarkers for depression: recent insights, current challenges and future prospects. Focus (American Psychiatric Publishing). 2018;16:194–209.
  • Schneider B, Prvulovic D. Novel biomarkers in major depression. Curr Opin Psychiatry. 2013;26:47–53.
  • Kuffel A, Eikelmann S, Terfehr K, et al. Noradrenergic blockade and memory in patients with major depression and healthy participants. Psychoneuroendocrinology. 2014;40:86–90.
  • Maletic V, Eramo A, Gwin K, et al. The role of norepinephrine and its α-adrenergic receptors in the pathophysiology and treatment of major depressive disorder and schizophrenia: a systematic review. Front Psychiatry. 2017;8:42.
  • Chandley MJ, Szebeni K, Szebeni A, et al. Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder. J Psychiatry Neurosci. 2013;38:276–284.
  • van Diermen L, van den Ameele S, Kamperman AM, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br J Psychiatry. 2018;212:71–80.
  • Bian Y, Yang L, Zhao M, et al. Identification of key genes and pathways in post-traumatic stress disorder using microarray analysis. Front Psychol. 2019;10:302.
  • Zhao Y, Zhu J, Shi B, et al. The transcription factor LEF1 promotes tumorigenicity and activates the TGF-β signaling pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2019;38:304.
  • Leday GGR, Vértes PE, Richardson S, et al. Replicable and coupled changes in innate and adaptive immune gene expression in two case-control studies of blood microarrays in major depressive disorder. Biol Psychiatry. 2018;83:70–80.
  • Vaváková M, Ďuračková Z, Trebatická J. Markers of oxidative stress and neuroprogression in depression disorder. Oxid Med Cell Longev. 2015;2015:898393.
  • Ghasemi M. Nitric oxide: antidepressant mechanisms and inflammation. Adv Pharmacol. 2019;86:121–152.
  • Chhibber A, Woody SK, Karim Rumi MA, et al. Estrogen receptor β deficiency impairs BDNF-5-HT(2A) signaling in the hippocampus of female brain: A possible mechanism for menopausal depression. Psychoneuroendocrinology. 2017;82:107–116.
  • Murakami G, Hojo Y, Ogiue-Ikeda M, et al. Estrogen receptor KO mice study on rapid modulation of spines and long-term depression in the hippocampus. Brain Res. 2015;1621:133–146.
  • Mehta D, Newport DJ, Frishman G, et al. Early predictive biomarkers for postpartum depression point to a role for estrogen receptor signaling. Psychol Med. 2014;44:2309–2322.
  • Hu Y, Hong XY, Yang XF, et al. Inflammation-dependent ISG15 upregulation mediates MIA-induced dendrite damages and depression by disrupting NEDD4/Rap2A signaling. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1477–1489.